Everest Organics files first US DMF

04 Sep 2019 Evaluate

Everest Organics has submitted the first US DMF for Esomeprazole Magnesium API.

Ever since the successful USFDA approval received for its manufacturing facility, the company has placed a separate focus to strengthen its presence in regulatory markets. With the first filing of US-DMF for Esomeprazole Magnesium, the company focuses to increase presence in the US market for substantial revenue generation.

Everest Organics is a fast growing API and Bulk drug manufacturing company with world class facility and it is committed to manufacturing excellent quality products and customer service.

Everest Organics Share Price

165.00 2.25 (1.38%)
May 20, 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 915.70
Cipla 977.90
Dr. Reddy's Lab 4248.20
Aurobindo Pharma 557.05
Lupin 638.75
View more..